Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation: 18/11/2021, Revision: 8, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 February 2026 - 13:00

Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation: 18/11/2021, Revision: 8, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/qinlock

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters